Phenoxybenzamine Hydrochloride (Par Pharmaceutical, Inc.)


Welcome to the PulseAid listing for the Phenoxybenzamine Hydrochloride drug offered from Par Pharmaceutical, Inc.. This Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical, Inc.
NON-PROPRIETARY NAME: Phenoxybenzamine Hydrochloride
SUBSTANCE NAME: PHENOXYBENZAMINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-01-24
END MARKETING DATE: 0000-00-00


Phenoxybenzamine Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPhenoxybenzamine Hydrochloride from Par Pharmaceutical, Inc.
LABELER NAME: Par Pharmaceutical, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2017-01-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49884-038_f87b03a4-ea46-4c56-b514-90067e630da7
PRODUCT NDC: 49884-038
APPLICATION NUMBER: ANDA204522

Other PHENOXYBENZAMINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Concordia Pharmaceuticals Inc.Dibenzyline
Par Pharmaceutical, Inc.Phenoxybenzamine Hydrochloride
Prasco LaboratoriesPhenoxybenzamine Hydrochloride
West-Ward Pharmaceuticals Corp.Phenoxybenzamine Hydrochloride